ANKSIOZNOST, DEPRESIJA I KVALITET ŽIVOTA KOD BOLESNIKA SA GLAUKOMOM
Sažetak
Prethodne studije pokazale su značajan komorbiditet između depresivnih i anksioznih poremećaja i glaukoma, koji je drugi najčešći uzrok gubitka vida u svetu. Ova studija imala je za cilj utvrđivanje prisustva depresije i anksioznosti, kao i procenu kvaliteta života bolesnika sa glaukomom, uz upoređivanje ovih rezultata sa rezultatima zdrave populacije. Studija preseka sprovedena je na Klinici za oftalmologiju, Univerzitetskog kliničkog centra Niš. Prisustvo anksioznosti i depresije procenjeno je pomoću Zungovih instrumenata za samoocenjivanje anksioznosti i depresije, a kvalitet života procenjen je pomoću SZO instrumenta za kvalitet života – kratka verzija. Prikupljeni su sociodemografski parametri i parametri vezani za glaukom. Oko 38,64% bolesnika sa glaukomom imalo je depresiju, uglavnom blage i umerene forme, dok je blaga depresija konstatovana kod 4,17% ispitanika u kontrolnoj grupi. Broj bolesnika sa anksioznošću bio je dva puta veći u eksperimentalnoj nego u kontrolnoj grupi. Navedeni rezultati pokazuju statistički relevantnu razliku (p < 0,01). Takođe utvrđena je statistički relevantna korelacija između učestalosti depresije i težine glaukoma (p < 0,001), dok između anksioznosti i težine glaukoma (p > 0,05) takva korelacija nije pronađena. Upoređujući prikupljene vrednosti za svaki domen, kao i ukupni kvalitet života, pronašli smo statistički relevantnu razliku (p < 0,001). Utvrđena je statistički značajna korelacija između bolesnika sa blažim i težim oblicima glaukoma. Komorbidna depresija i anksioznost kod bolesnika sa glaukomom javljaju se kod težih oblika glaukoma, kod bolesnika sa dužim trajanjem bolesti iz medicinskih i psiho-socijalnih razloga.
Reference
Normal
0
false
false
false
EN-US
X-NONE
X-NONE
DefSemiHidden="false" DefQFormat="false" DefPriority="99"
LatentStyleCount="371">
UnhideWhenUsed="true" QFormat="true" Name="heading 2"/>
UnhideWhenUsed="true" QFormat="true" Name="heading 3"/>
UnhideWhenUsed="true" QFormat="true" Name="heading 4"/>
UnhideWhenUsed="true" QFormat="true" Name="heading 5"/>
UnhideWhenUsed="true" QFormat="true" Name="heading 6"/>
UnhideWhenUsed="true" QFormat="true" Name="heading 7"/>
UnhideWhenUsed="true" QFormat="true" Name="heading 8"/>
UnhideWhenUsed="true" QFormat="true" Name="heading 9"/>
Name="index 1"/>
Name="index 2"/>
Name="index 3"/>
Name="index 4"/>
Name="index 5"/>
Name="index 6"/>
Name="index 7"/>
Name="index 8"/>
Name="index 9"/>
UnhideWhenUsed="true" Name="toc 1"/>
UnhideWhenUsed="true" Name="toc 2"/>
UnhideWhenUsed="true" Name="toc 3"/>
UnhideWhenUsed="true" Name="toc 4"/>
UnhideWhenUsed="true" Name="toc 5"/>
UnhideWhenUsed="true" Name="toc 6"/>
UnhideWhenUsed="true" Name="toc 7"/>
UnhideWhenUsed="true" Name="toc 8"/>
UnhideWhenUsed="true" Name="toc 9"/>
Name="Normal Indent"/>
Name="footnote text"/>
Name="annotation text"/>
Name="header"/>
Name="footer"/>
Name="index heading"/>
UnhideWhenUsed="true" QFormat="true" Name="caption"/>
Name="table of figures"/>
Name="envelope address"/>
Name="envelope return"/>
Name="footnote reference"/>
Name="annotation reference"/>
Name="line number"/>
Name="page number"/>
Name="endnote reference"/>
Name="endnote text"/>
Name="table of authorities"/>
Name="macro"/>
Name="toa heading"/>
Name="List"/>
Name="List Bullet"/>
Name="List Number"/>
Name="List 2"/>
Name="List 3"/>
Name="List 4"/>
Name="List 5"/>
Name="List Bullet 2"/>
Name="List Bullet 3"/>
Name="List Bullet 4"/>
Name="List Bullet 5"/>
Name="List Number 2"/>
Name="List Number 3"/>
Name="List Number 4"/>
Name="List Number 5"/>
Name="Closing"/>
Name="Signature"/>
UnhideWhenUsed="true" Name="Default Paragraph Font"/>
UnhideWhenUsed="true" Name="Body Text"/>
Name="Body Text Indent"/>
Name="List Continue"/>
Name="List Continue 2"/>
Name="List Continue 3"/>
Name="List Continue 4"/>
Name="List Continue 5"/>
Name="Message Header"/>
Name="Salutation"/>
Name="Date"/>
Name="Body Text First Indent"/>
Name="Body Text First Indent 2"/>
Name="Note Heading"/>
Name="Body Text 2"/>
Name="Body Text 3"/>
Name="Body Text Indent 2"/>
Name="Body Text Indent 3"/>
Name="Block Text"/>
Name="Hyperlink"/>
Name="FollowedHyperlink"/>
Name="Document Map"/>
Name="Plain Text"/>
Name="E-mail Signature"/>
Name="HTML Top of Form"/>
Name="HTML Bottom of Form"/>
Name="Normal (Web)"/>
Name="HTML Acronym"/>
Name="HTML Address"/>
Name="HTML Cite"/>
Name="HTML Code"/>
Name="HTML Definition"/>
Name="HTML Keyboard"/>
Name="HTML Preformatted"/>
Name="HTML Sample"/>
Name="HTML Typewriter"/>
Name="HTML Variable"/>
Name="Normal Table"/>
Name="annotation subject"/>
Name="No List"/>
Name="Outline List 1"/>
Name="Outline List 2"/>
Name="Outline List 3"/>
Name="Table Simple 1"/>
Name="Table Simple 2"/>
Name="Table Simple 3"/>
Name="Table Classic 1"/>
Name="Table Classic 2"/>
Name="Table Classic 3"/>
Name="Table Classic 4"/>
Name="Table Colorful 1"/>
Name="Table Colorful 2"/>
Name="Table Colorful 3"/>
Name="Table Columns 1"/>
Name="Table Columns 2"/>
Name="Table Columns 3"/>
Name="Table Columns 4"/>
Name="Table Columns 5"/>
Name="Table Grid 1"/>
Name="Table Grid 2"/>
Name="Table Grid 3"/>
Name="Table Grid 4"/>
Name="Table Grid 5"/>
Name="Table Grid 6"/>
Name="Table Grid 7"/>
Name="Table Grid 8"/>
Name="Table List 1"/>
Name="Table List 2"/>
Name="Table List 3"/>
Name="Table List 4"/>
Name="Table List 5"/>
Name="Table List 6"/>
Name="Table List 7"/>
Name="Table List 8"/>
Name="Table 3D effects 1"/>
Name="Table 3D effects 2"/>
Name="Table 3D effects 3"/>
Name="Table Contemporary"/>
Name="Table Elegant"/>
Name="Table Professional"/>
Name="Table Subtle 1"/>
Name="Table Subtle 2"/>
Name="Table Web 1"/>
Name="Table Web 2"/>
Name="Table Web 3"/>
Name="Balloon Text"/>
Name="Table Theme"/>
Name="List Paragraph"/>
Name="Intense Quote"/>
Name="Subtle Emphasis"/>
Name="Intense Emphasis"/>
Name="Subtle Reference"/>
Name="Intense Reference"/>
UnhideWhenUsed="true" Name="Bibliography"/>
UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"/>
Name="Grid Table 1 Light Accent 1"/>
Name="Grid Table 6 Colorful Accent 1"/>
Name="Grid Table 7 Colorful Accent 1"/>
Name="Grid Table 1 Light Accent 2"/>
Name="Grid Table 6 Colorful Accent 2"/>
Name="Grid Table 7 Colorful Accent 2"/>
Name="Grid Table 1 Light Accent 3"/>
Name="Grid Table 6 Colorful Accent 3"/>
Name="Grid Table 7 Colorful Accent 3"/>
Name="Grid Table 1 Light Accent 4"/>
Name="Grid Table 6 Colorful Accent 4"/>
Name="Grid Table 7 Colorful Accent 4"/>
Name="Grid Table 1 Light Accent 5"/>
Name="Grid Table 6 Colorful Accent 5"/>
Name="Grid Table 7 Colorful Accent 5"/>
Name="Grid Table 1 Light Accent 6"/>
Name="Grid Table 6 Colorful Accent 6"/>
Name="Grid Table 7 Colorful Accent 6"/>
Name="List Table 1 Light Accent 1"/>
Name="List Table 6 Colorful Accent 1"/>
Name="List Table 7 Colorful Accent 1"/>
Name="List Table 1 Light Accent 2"/>
Name="List Table 6 Colorful Accent 2"/>
Name="List Table 7 Colorful Accent 2"/>
Name="List Table 1 Light Accent 3"/>
Name="List Table 6 Colorful Accent 3"/>
Name="List Table 7 Colorful Accent 3"/>
Name="List Table 1 Light Accent 4"/>
Name="List Table 6 Colorful Accent 4"/>
Name="List Table 7 Colorful Accent 4"/>
Name="List Table 1 Light Accent 5"/>
Name="List Table 6 Colorful Accent 5"/>
Name="List Table 7 Colorful Accent 5"/>
Name="List Table 1 Light Accent 6"/>
Name="List Table 6 Colorful Accent 6"/>
Name="List Table 7 Colorful Accent 6"/>
/* Style Definitions */
table.MsoNormalTable
{mso-style-name:"Table Normal";
mso-tstyle-rowband-size:0;
mso-tstyle-colband-size:0;
mso-style-noshow:yes;
mso-style-priority:99;
mso-style-parent:"";
mso-padding-alt:0in 5.4pt 0in 5.4pt;
mso-para-margin-top:0in;
mso-para-margin-right:0in;
mso-para-margin-bottom:8.0pt;
mso-para-margin-left:0in;
line-height:107%;
mso-pagination:widow-orphan;
font-size:11.0pt;
font-family:"Calibri","sans-serif";
mso-ascii-font-family:Calibri;
mso-ascii-theme-font:minor-latin;
mso-hansi-font-family:Calibri;
mso-hansi-theme-font:minor-latin;
mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;}
Agorastos A, Skevas C, Matthaei M, Otte C, Klemm M, Richard G et al: Depression, anxiety, and disturbed sleepin glaucoma. J Neuropsychiatry Clin Neurosci 2013;25:205-13. [CrossRef] [PubMed]
Bali SJ, Parmar T, Arora V, et al. Evaluation of major depressive disorder in patients receiving chronic treat-ment with topical timolol. Ophthalmologica 2011;226: 157-60. [CrossRef] [PubMed]
Fasih U, Hamirani MM, Jafri AR, et al. Assessment of anxiety and depression in primary open angle glaucoma patients (a study of 100 cases). Pak J Ophthalmol 2010;26:143-7.
Kong X, Yan M, Sun X, Xiao Z: Anxiety and De-pression are More Prevalent in Primary Angle Closure Glaucoma Than in Primary Open-Angle Glaucoma. J Glaucoma 2015;24(5):e57-63.24. [CrossRef] [PubMed]
Kong XM, Zhu WQ, Hong JX, Sun XH: Is glaucoma comprehension associated with psychological disturb-ance and vision-related quality of life for patients with glaucoma? A cross-sectional study. BMJ Open 2014; 26:4(5):e004632. [CrossRef] [PubMed]
Lim NC, Fan CH, Yong MK et al. Assessment of Depression, Anxiety, and Quality of Life in Singapo-rean Patients With Glaucoma. J Glaucoma 2016; 25(7):1605-12. [CrossRef] [PubMed]
Loon SC, Jin J, Jin Goh M. The relationship between quality of life and adherence to medication in glaucoma patients in Singapore. J Glaucoma 2015;24: e36-e42. [CrossRef] [PubMed]
Mabuchi F, Yoshimura K, Kashiwagi K, et al. High prevalence of anxiety and depression in patients with primary open-angle glaucoma. J Glaucoma 2008;17: 552-7. [CrossRef] [PubMed]
Mabuchi F, Yoshimura K, Kashiwagi K, et al. Risk factors for anxiety and depression in patients with glaucoma. Br J Ophthalmol 2012;96:821-5. [CrossRef] [PubMed]
Marić V. Ispitivanje prediktora za nastanak pseudo-eksfolijativnog glaukoma. Doktorska disertacija. Univerzitet u Beogradu Medicinski fakultet; 2019.
Pelcic G, Ljubicic R, Barac J. et al. Glaucoma, depression and quality of life: Multiple comorbidities, multiple assessments and multidisciplinary plan treat-ment. Psychiatria Danubina 2017;29(3):351-9. [CrossRef] [PubMed]
Pop-Jordanova N, Ristova J, Loleska S: Depression in ophthalmological patients. Prilozi 2014;35(2):53-8. [CrossRef] [PubMed]
Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. The British Journal of Ophthalmology 2006;90(3): 262-7. [CrossRef] [PubMed]
Ramulu PY, Swenor BK, Jefferys JL, et al. Difficulty with outloud and silent reading in glaucoma. Invest Ophthalmol Vis Sci 2013;54:666-72. [CrossRef] [PubMed]
Ramulu PY, West SK, Munoz B, et al. Driving cessation and driving limitation in glaucoma: the Salisbury Eye Evaluation Project. Ophthalmology 2009;116:1846-53. [CrossRef] [PubMed]
Skalicky S, Goldberg I. Depression and quality of life in patients with glaucoma: a cross-sectional analysis using the Geriatric Depression Scale-15, assessment of function related to vision, and the Glaucoma Quality of Life-15. J Glaucoma 2008;17:546-51. [CrossRef] [PubMed]
Tastan S, Iyigun E, Bayer A, et al. Anxiety, depression and quality of life in Turkish patients with glaucoma. Psychol Rep 2010;106:343-57. [CrossRef] [PubMed]
Wang SY, Singh K, Lin SC. Prevalence and predictors of depression among participants with glaucoma in a nationally representative population sample. Am J Ophthalmol 2012;154:436-44. [CrossRef] [PubMed]
Zhou C, Qian S, Wu P, et al. Anxiety and depression in Chinese patients with glaucoma: sociodemographic, clinical and self-reported correlates. J Psychosom Res 2013;75:75-82. [CrossRef] [PubMed]